JeffreySosmanMD

Hematology • Chicago, IL

Professor of Medicine, Vanderbilt University

Join to view full profile

Dr. Sosman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sosman's full profile

Already have an account?

Office
675 N Saint Clair St
Ste 21-100
Chicago, IL 60611
Phone+1 312-695-0990

Fax+1 312-695-1106

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1986 - 1989
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1985 - 1986
University of ChicagoResidency, Pathology-Anatomic and Clinical, 1982 - 1985
University of ChicagoInternship, Internal Medicine, 1981 - 1982
Albert Einstein College of MedicineClass of 1981

Certifications & Licensure

IL State Medical License 1983 - 2026
TN State Medical License 2001 - 2016
WI State Medical License 1985 - 1989
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
American Board of Pathology Anatomic Pathology

Clinical Trials

Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma Start of enrollment: 2019 Oct 28
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

Successful treatment of in-transit metastatic melanoma with combination intralesional T-VEC and topical imiquimod immunotherapy.
Marisa Lenga, Esther Choi, Jeffrey Sosman, Sunandana Chandra, Danielle Lam
Journal for Immunotherapy of Cancer. 2024-11-19
Combined PD-1 and CTLA-4 Blockade in an International Cohort of Patients with Acral Lentiginous Melanoma.
Erin McGillivray, Karam Ashouri, Eftychia Chatziioannou, Jesús Antonio Ocejo Gallegos, Jabra Zarka
The British Journal of Dermatology. 2024-10-23
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy.
Zachary Z Reinstein, Yue Zhang, Oscar E Ospina, Matt D Nichols, Victoria A Chu
Cancer Discovery. 2024-09-04

Press Mentions

Reversing Resistance to PD-1 Inhibitors with Combination Immunotherapy in Patients with Advanced MelanomaApril 8th, 2022
ECOG-ACRIN Cancer Research Group Melanoma Research Team Led by Michael Atkins, MD, Receives the 2023 Paper of the Year Distinction from the Journal of Clinical OncologyJanuary 19th, 2024